Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs

A diagnosis of advanced ovarian cancer is the beginning of a long and arduous journey for a patient. Worldwide, approximately half of the individuals undergoing therapy for advanced cancer will succumb to the disease, or consequences of treatment. Well-known and widely-used chemotherapeutic agents s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rath, Kellie S, McCann, Georgia A, Cohn, David E, Rivera, Brian K, Kuppusamy, Periannan, Selvendiran, Karuppaiyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665575/
https://www.ncbi.nlm.nih.gov/pubmed/23663277
http://dx.doi.org/10.1186/1757-2215-6-35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665575/
https://www.ncbi.nlm.nih.gov/pubmed/23663277
http://dx.doi.org/10.1186/1757-2215-6-35

Ejemplares similares